Global Cell Imagers Market 2017-2021
About Cell Imagers
Cell imaging is the study of examining cell structures through various devices such as microscopes to better understand cellular mechanisms to help diagnose diseases and discover drugs. There are several methods of cell imaging, which include fluorescence microscopy (FM), high content screening (HCS), in situ hybridization (ISH), confocal laser scanning microscopy (CLSM), immunofluorescence imaging (IFI), super-resolution microscopy (SRM), and automated imaging. Some critical factors such as the maintenance of healthy cells at the microscope stage and the establishment of a feasible environment that is ideal for cells and does not affect their functionalities need to be ensured during cell imaging.
Technavio’s analysts forecast the global cell imagers market to grow at a CAGR of 8.21% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global cell imagers market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales cell imagers.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Cell Imagers Market 2017-2021
Technavio recognizes the following companies as the key players in the global cell imagers market: ZEISS International, Leica Microsystems, GE Healthcare, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: ATTO Corporation, Biological Industries, BioTek Instruments, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, Enzo Life Sciences, Nikon Corporation, Olympus Corporation, and PerkinElmer.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is extensive use of automation in live cell imaging. Cell imaging is an important tool for the efficient study of cell biology and discovery of drugs. Hence, the automation of cell imaging can reduce the time spent by researchers on tasks such as sample loading, which allows them to spend time on analyzing and interpreting the results obtained from cell imaging. Automated microscopy solutions are offered by most vendors and are being increasingly deployed in various diagnostic centers and research laboratories. These solutions increase the overall lab output as they assist in analyzing more samples.”
According to the report, one of the major drivers for this market is growing prevalence of chronic diseases. Globally, chronic diseases such as cancer, diabetes, arthritis, heart diseases, and stroke are the leading causes of deaths. The prevalence of these diseases is increasing at alarming rates. The CDC estimates that by 2020, the number of new cancer cases is expected to increase by nearly 2 million each year.
Further, the report states that one of the major factors hindering the growth of this market is technical and economic challenges of super resolution. To achieve better results and generate more insights about cellular processes, there has been an immense need to develop imaging equipment that provide better resolution. However, the various approaches used to achieve this have been ineffective to solve real-world problems. Issues related to resolution have been the most common cited challenge among key opinion leaders at various annual conferences held to discuss advancements and issues related to microscopy.
ZEISS International, Leica Microsystems, GE Healthcare, Thermo Fisher Scientific, ATTO Corporation, Biological Industries, BioTek Instruments, Bio-Rad Laboratories, Becton Dickinson (BD), Essen Bioscience, Enzo Life Sciences, Nikon Corporation, Olympus Corporation, and PerkinElmer.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook